Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.

PubWeight™: 1.48‹?› | Rank: Top 4%

🔗 View Article (PMID 16516275)

Published in Thromb Res on March 03, 2006

Authors

Susan R Kahn1, Akbar Panju, William Geerts, Graham F Pineo, Louis Desjardins, Alexander G G Turpie, Stanislav Glezer, Lehana Thabane, Rolf J Sebaldt, CURVE study investigators

Author Affiliations

1: Department of Medicine, McGill University, SMBD Jewish General Hospital, Canada. susan.kahn@mcgill.ca

Associated clinical trials:

Weight Based Enoxaparin in Trauma Patients (WeBET) | NCT01916707

Articles citing this

Physician alerts to prevent symptomatic venous thromboembolism in hospitalized patients. Circulation (2009) 1.66

Venous thromboembolism-related mortality and morbidity in King Fahd General Hospital, Jeddah, Kingdom of Saudi Arabia. Ann Thorac Med (2011) 1.56

Cancer, clots and consensus: new understanding of an old problem. J Clin Oncol (2009) 1.35

Designing and implementing effective venous thromboembolism prevention protocols: lessons from collaborative efforts. J Thromb Thrombolysis (2010) 1.26

Thromboprophylaxis with low-molecular-weight heparin in medical patients with cancer. Cancer (2009) 0.90

Perioperative pharmacologic prophylaxis for venous thromboembolism in colorectal surgery. J Am Coll Surg (2011) 0.89

Cancer and venous thromboembolic disease: from molecular mechanisms to clinical management. Curr Oncol (2014) 0.88

The potential benefits of low-molecular-weight heparins in cancer patients. J Hematol Oncol (2010) 0.87

Computerized decision support for the cardiovascular clinician: applications for venous thromboembolism prevention and beyond. Circulation (2009) 0.86

Prevention of venous thromboembolism in hospitalized patients with cancer. J Clin Oncol (2009) 0.85

Infection and venous thromboembolism in patients undergoing colorectal surgery: what is the relationship? Dis Colon Rectum (2014) 0.84

Strategies to enhance venous thromboprophylaxis in hospitalized medical patients (SENTRY): a pilot cluster randomized trial. Implement Sci (2013) 0.84

Implementing thrombosis guidelines in cancer patients: a review. Rambam Maimonides Med J (2014) 0.83

Prevention of venous thromboembolism in medical patients and outpatients. Nat Rev Cardiol (2009) 0.82

Venous thromboembolism in patients with diabetes mellitus. Am J Med (2012) 0.82

Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start). J Thromb Thrombolysis (2010) 0.80

Venous thromboembolism in nursing home residents: role of selected risk factors. J Am Geriatr Soc (2012) 0.80

Assessment of risk and prophylaxis for deep vein thrombosis and pulmonary embolism in medically ill patients during their early days of hospital stay at a tertiary care center in a developing country. Vasc Health Risk Manag (2009) 0.80

Venous thromboembolism prophylaxis for hospitalized medical patients, current status and strategies to improve. Ann Thorac Med (2010) 0.80

Venous thromboembolic events in hospitalised medical patients. Thromb Haemost (2009) 0.78

Primary prevention of venous thromboembolism in elderly medical patients. Clin Interv Aging (2008) 0.78

Cancer and Venous Thromboembolic Disease: A Review. Oncologist (2017) 0.78

Adherence to local guidelines for venous thromboprophylaxis: a cross-sectional study of medical inpatients in Argentina. Thromb J (2011) 0.77

Colectomy is a risk factor for venous thromboembolism in ulcerative colitis. World J Gastroenterol (2015) 0.76

Venous thromboembolism prophylaxis in patients undergoing abdominal and pelvic cancer surgery: adherence and compliance to ACCP guidelines in DIONYS registry. Springerplus (2016) 0.75

Improving venous thromboembolism risk assessment compliance using the electronic tool in admitted medical patients. BMJ Qual Improv Rep (2015) 0.75

Successful retreatment with osimertinib after osimertinib-induced acute pulmonary embolism in a patient with lung adenocarcinoma: A case report. Respir Med Case Rep (2016) 0.75

Postoperative venous thromboembolism prophylaxis by general surgeons in a developing country: a survey. Thrombosis (2013) 0.75

[Thrombosis prophylaxis in geriatric patients]. Z Gerontol Geriatr (2012) 0.75

Evaluation of venous thromboembolism prophylaxis in a major hospital in a developing country. Int J Clin Pharm (2017) 0.75

Articles by these authors

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 16.17

Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet (2010) 12.92

Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 11.84

Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA (2006) 11.71

Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. N Engl J Med (2015) 10.86

Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med (2003) 8.55

Randomized trial of primary PCI with or without routine manual thrombectomy. N Engl J Med (2015) 7.83

Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis. N Engl J Med (2014) 6.65

A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med (2003) 6.57

Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA (2008) 6.39

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med (2008) 6.32

Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med (2008) 6.00

Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial. Ann Intern Med (2010) 5.79

Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology (2013) 5.69

Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer. N Engl J Med (2012) 5.25

Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med (2003) 5.02

The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison. Lancet (2007) 4.99

Dalteparin versus unfractionated heparin in critically ill patients. N Engl J Med (2011) 4.59

Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA (2012) 4.58

Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison. Lancet (2002) 4.21

Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med (2014) 3.96

Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation (2004) 3.83

Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP). BMJ (2011) 3.81

Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ (2006) 3.58

Femoral nerve block improves analgesia outcomes after total knee arthroplasty: a meta-analysis of randomized controlled trials. Anesthesiology (2010) 3.42

The safety of long-acting beta-agonists among patients with asthma using inhaled corticosteroids: systematic review and metaanalysis. Am J Respir Crit Care Med (2008) 3.01

Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer. J Clin Endocrinol Metab (2004) 2.86

Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis. Thyroid (2009) 2.79

Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study. CMAJ (2009) 2.64

Bayesian meta-analysis of hormone therapy and mortality in younger postmenopausal women. Am J Med (2009) 2.64

Individualized electronic decision support and reminders to improve diabetes care in the community: COMPETE II randomized trial. CMAJ (2009) 2.58

Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. Arch Intern Med (2004) 2.34

Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest (2007) 2.32

Application of data mining techniques in pharmacovigilance. Br J Clin Pharmacol (2004) 2.32

Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? Int J Epidemiol (2008) 2.31

Does the clinical examination predict lower extremity peripheral arterial disease? JAMA (2006) 2.29

Thrombocytopenia in critically ill patients receiving thromboprophylaxis: frequency, risk factors, and outcomes. Chest (2013) 2.24

Quality of reporting of randomized controlled trials in general endocrinology literature. J Clin Endocrinol Metab (2008) 2.24

Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients*. Crit Care Med (2015) 2.16

Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature. Circulation (2012) 2.16

The efficacy of botulinum toxin type A in managing chronic musculoskeletal pain: a systematic review and meta analysis. Inflammopharmacology (2010) 2.11

The Cameroon Mobile Phone SMS (CAMPS) trial: a randomized trial of text messaging versus usual care for adherence to antiretroviral therapy. PLoS One (2012) 2.05

Meta-analysis: cardiovascular events associated with nonsteroidal anti-inflammatory drugs. Am J Med (2006) 2.02

The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis--a simulation study. PLoS One (2011) 2.02

Alternatives to project-specific consent for access to personal information for health research: what is the opinion of the Canadian public? J Am Med Inform Assoc (2007) 1.98

Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry. PLoS One (2013) 1.97

A systematic review and meta-analysis of studies using the STRATIFY tool for prediction of falls in hospital patients: how well does it work? Age Ageing (2008) 1.94

The HAART cell phone adherence trial (WelTel Kenya1): a randomized controlled trial protocol. Trials (2009) 1.92

Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med (2008) 1.91

Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism. Cochrane Database Syst Rev (2013) 1.88

Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer. Am J Med (2006) 1.88

Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors. Crit Care Med (2005) 1.87

Measuring patient preferences for colorectal cancer screening using a choice-format survey. Value Health (2007) 1.86

Views on health information sharing and privacy from primary care practices using electronic medical records. Int J Med Inform (2010) 1.83

Male involvement in prevention programs of mother to child transmission of HIV: a systematic review to identify barriers and facilitators. Syst Rev (2013) 1.82

Hypotonic versus isotonic maintenance fluids after surgery for children: a randomized controlled trial. Pediatrics (2011) 1.82

Gabapentin does not improve multimodal analgesia outcomes for total knee arthroplasty: a randomized controlled trial. Can J Anaesth (2013) 1.80

Prevention of venous thromboembolism. Chest (2005) 1.76

Computerized clinical decision support systems for chronic disease management: a decision-maker-researcher partnership systematic review. Implement Sci (2011) 1.70

Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators. Chest (2010) 1.67

Does this patient with diabetes have large-fiber peripheral neuropathy? JAMA (2010) 1.66

Mobile phone text messages for improving adherence to antiretroviral therapy (ART): an individual patient data meta-analysis of randomised trials. BMJ Open (2013) 1.66

Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients: a subgroup analysis of the PREVENT trial. Arch Intern Med (2005) 1.64

Exercise for improving outcomes after osteoporotic vertebral fracture. Cochrane Database Syst Rev (2013) 1.63

Association between framing of the research question using the PICOT format and reporting quality of randomized controlled trials. BMC Med Res Methodol (2010) 1.63

Pregnancy outcomes in women with chronic kidney disease: a systematic review. Clin J Am Soc Nephrol (2011) 1.59

Screening and prevention of venous thromboembolism in critically ill patients: a decision analysis and economic evaluation. Am J Respir Crit Care Med (2011) 1.58

Venous thromboembolism prophylaxis in medical inpatients: a retrospective chart review. Thromb Res (2003) 1.57

Sex differences in hospital admissions from emergency departments in asthmatic adults: a population-based study. Ann Allergy Asthma Immunol (2006) 1.57

Helicobacter pylori eradication: novel therapy for immune thrombocytopenic purpura? A review of the literature. Am J Hematol (2005) 1.56

Features predicting the success of computerized decision support for prescribing: a systematic review of randomized controlled trials. BMC Med Inform Decis Mak (2009) 1.55

Assessment of the quality and variability of health information on chronic pain websites using the DISCERN instrument. BMC Med (2010) 1.55

"Sleepiness" is serious in adolescence: two surveys of 3235 Canadian students. BMC Public Health (2006) 1.53

Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: a pilot study. J Crit Care (2005) 1.50

The impact of incident vertebral and non-vertebral fractures on health related quality of life in postmenopausal women. BMC Musculoskelet Disord (2002) 1.47

A dose-finding study with TAK-442, an oral factor Xa inhibitor, in patients undergoing elective total knee replacement surgery. Thromb Haemost (2010) 1.47

Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes. Anesthesiology (2014) 1.47

Does acetyl salicylic acid (ASA) have a role in the prevention of venous thromboembolism? Br J Haematol (2009) 1.46

Preferences for evidence-based practice dissemination in addiction agencies serving women: a discrete-choice conjoint experiment. Addiction (2012) 1.45

An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer. Endocrinol Metab Clin North Am (2008) 1.44

Prospective evaluation of health-related quality of life in patients with deep venous thrombosis. Arch Intern Med (2005) 1.43

Sample sizes for clinical trials using sputum eosinophils as a primary outcome. Eur Respir J (2013) 1.42

Patient information about warfarin: an assessment of accuracy and readability. JAMA Intern Med (2013) 1.42

Quality of randomized controlled trials reporting in the primary treatment of brain tumors. J Clin Oncol (2006) 1.42

A randomized pilot study of dalteparin versus unfractionated heparin during percutaneous coronary interventions. Am Heart J (2006) 1.41

Effect of cardiovascular comorbidities and concomitant aspirin use on selection of cyclooxygenase inhibitor among rheumatologists. Arthritis Rheum (2005) 1.40

Computerized clinical decision support systems for primary preventive care: a decision-maker-researcher partnership systematic review of effects on process of care and patient outcomes. Implement Sci (2011) 1.40

Venous thromboembolism in amyotrophic lateral sclerosis: a prospective study. Neurology (2014) 1.40

Population pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor Xa inhibitor--in patients undergoing major orthopaedic surgery. Clin Pharmacokinet (2008) 1.39

The correlation between esophageal and abdominal pressures in mechanically ventilated patients undergoing laparoscopic surgery. Respir Care (2013) 1.39

Prophylactic antibiotic regimens in tumour surgery (PARITY): protocol for a multicentre randomised controlled study. BMJ Open (2012) 1.38

Attitudes of women who are currently using or recently stopped estrogen replacement therapy with or without progestins: results of the AWARE survey. J Obstet Gynaecol Can (2004) 1.38

Metastatic renal cell cancer treatments: an indirect comparison meta-analysis. BMC Cancer (2009) 1.37

Consent for use of personal information for health research: do people with potentially stigmatizing health conditions and the general public differ in their opinions? BMC Med Ethics (2009) 1.36

Emergency Department and Walk-in Clinic Use in Models of Primary Care Practice with Different After-Hours Accessibility in Ontario. Healthc Policy (2008) 1.36

Comparing methods to estimate treatment effects on a continuous outcome in multicentre randomized controlled trials: a simulation study. BMC Med Res Methodol (2011) 1.34

Alternatives to project-specific consent for access to personal information for health research: insights from a public dialogue. BMC Med Ethics (2008) 1.33

Evolution of heterogeneity (I2) estimates and their 95% confidence intervals in large meta-analyses. PLoS One (2012) 1.33